Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Brian Godman, Rickard E Malmström, Eduardo Diogene, Andy Gray, Sisira Jayathissa, Angela Timoney, Francisco Acurcio, Ali Alkan, Anna Brzezinska, Anna Bucsics, Stephen M Campbell, Jadwiga Czeczot, Winnie de Bruyn, Irene Eriksson, Faridah Aryani Md Yusof, Alexander E Finlayson, Jurij Fürst, Kristina Garuoliene, Augusto Guerra Júnior, Jolanta Gulbinovič, Saira Jan, Roberta Joppi, Marija Kalaba, Einar Magnisson, Laura McCullagh, Kaisa Miikkulainen, Gabriela Ofierska-Sujkowska, Hanne Bak Pedersen, Gisbert Selke, Catherine Sermet, Susan Spillane, Azuwana Supian, Ilse Truter, Vera Vlahović-Palčevski, Low Ee Vien, Elif H Vural, Janet Wale, Magdałene Władysiuk, Wenjie Zeng & Lars L Gustafsson. (2015) Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?. Expert Review of Clinical Pharmacology 8:1, pages 77-94.
Read now
Read now
Pieter Dylst, Arnold G Vulto & Steven Simoens. (2014) Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability. Expert Review of Pharmacoeconomics & Outcomes Research 14:3, pages 345-353.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Jessica Fraeyman, Guido Van Hal, Brian Godman & Philippe Beutels. (2013) The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 141-151.
Read now
Read now
Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer & Rickard E Malmström. (2012) Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 809-819.
Read now
Read now
Vanda Markovic-Pekovic, Ranko Škrbić, Brian Godman & Lars L Gustafsson. (2012) Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 661-671.
Read now
Read now
Ljiljana Sovic Brkicic, Brian Godman, Luka Voncina, Slavica Sovic & Maja Relja. (2012) Initiatives to improve prescribing efficiency for drugs to treat Parkinson’s disease in Croatia: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 373-384.
Read now
Read now
Mohammed Abuelkhair, Shajahan Abdu, Brian Godman, Sahar Fahmy, Rickard E Malmström & Lars L Gustafsson. (2012) Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 115-124.
Read now
Read now
Luka Vončina, Tihomir Strizrep, Brian Godman, Marion Bennie, Iain Bishop, Stephen Campbell, Vera Vlahović-Palčevski & Lars L Gustafsson. (2011) Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research 11:4, pages 469-479.
Read now
Read now
Kristina Garuoliene, Brian Godman, Jolanta Gulbinovič, Björn Wettermark & Alan Haycox. (2011) European countries with small populations can obtain low prices for drugs: Lithuania as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 11:3, pages 343-349.
Read now
Read now
Brian Godman, Solveig Sakshaug, Christian Berg, Björn Wettermark & Alan Haycox. (2011) Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs. Expert Review of Pharmacoeconomics & Outcomes Research 11:1, pages 121-129.
Read now
Read now
Brian Godman, William Shrank, Morten Andersen, Christian Berg, Iain Bishop, Thomas Burkhardt, Kristina Garuoliene, Harald Herholz, Roberta Joppi, Marija Kalaba, Ott Laius, Diane McGinn, Vita Samaluk, Catherine Sermet, Ulrich Schwabe, Inês Teixeira, Lesley Tilson, F Cankat Tulunay, Vera Vlahović-Palčevski, Kamila Wendykowska, Björn Wettermark, Corinne Zara & Lars L Gustafsson. (2010) Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Review of Pharmacoeconomics & Outcomes Research 10:6, pages 707-722.
Read now
Read now
Brian Godman, Anna Bucsics, Thomas Burkhardt, Manuela Schmitzer, Björn Wettermark & Peter Wieninger. (2010) Initiatives to enhance renin–angiotensin prescribing efficiency in Austria: impact and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 10:2, pages 199-207.
Read now
Read now
Diane McGinn, Brian Godman, Julie Lonsdale, Rosalind Way, Björn Wettermark & Alan Haycox. (2010) Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications. Expert Review of Pharmacoeconomics & Outcomes Research 10:1, pages 73-85.
Read now
Read now
Articles from other publishers (19)
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana S. Brkičić, Anna Bucsics, Guillaume Dedet, Jaran Eriksen, Joseph O. Fadare, Jurij Fürst, Gisselle Gallego, Isabella P. Godói, Augusto A. Guerra Júnior, Hakkı Gürsöz, Saira Jan, Jan Jones, Roberta Joppi, Saim Kerman, Ott Laius, Newman Madzikwa, Einar Magnússon, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O'Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalena Wladysiuk, Sotiris Vandoros, Elif H. Vural, Corinne Zara & Brian Godman. (2016) Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future. Frontiers in Pharmacology 7.
Crossref
Crossref
Petros Pechlivanoglou, Jaap E. Wieringa, Tim de Jager & Maarten J. Postma. (2015) The Effect of Financial and Educational Incentives on Rational Prescribing. A State-Space Approach. Health Economics 24:4, pages 439-453.
Crossref
Crossref
Brian Godman, Max Petzold, Kathleen Bennett, Marion Bennie, Anna Bucsics, Alexander E Finlayson, Andrew Martin, Marie Persson, Jutta Piessnegger, Emanuel Raschi, Steven Simoens, Corinne Zara & Corrado Barbui. (2014) Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications. BMC Medicine 12:1.
Crossref
Crossref
Mohamed Azmi Hassali, Alian A. Alrasheedy, Andrew McLachlan, Tuan Anh Nguyen, Saleh Karamah AL-Tamimi, Mohamed Izham Mohamed Ibrahim & Hisham Aljadhey. (2014) The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use. Saudi Pharmaceutical Journal 22:6, pages 491-503.
Crossref
Crossref
James C. Moon, Brian Godman, Max Petzold, Samantha Alvarez-Madrazo, Kathleen Bennett, Iain Bishop, Anna Bucsics, Ulrik Hesse, Andrew Martin, Steven Simoens, Corinne Zara & Rickard E. Malmström. (2014) Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Frontiers in Pharmacology 5.
Crossref
Crossref
R. Fernández Urrusuno, P. Pérez Pérez, M. C. Montero Balosa, C. Márquez Calzada & B. Pascual de la Pisa. (2013) Compliance with quality prescribing indicators linked to financial incentives: what about not incentivized indicators?: an observational study. European Journal of Clinical Pharmacology 70:3, pages 303-311.
Crossref
Crossref
Ana Luísa Caires de Souza, Francisco de Assis Acurcio, Augusto Afonso Guerra Júnior, Renata Cristina Rezende Macedo do Nascimento, Brian Godman & Leonardo Maurício Diniz. (2014) Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review. Applied Health Economics and Health Policy 12:1, pages 19-32.
Crossref
Crossref
. 2014. Aplicación del análisis coste-efectividad de los medicamentos y los programas de salud en la planificación sanitaria. Aplicación del análisis coste-efectividad de los medicamentos y los programas de salud en la planificación sanitaria
133
140
.
Pierluigi Paggiaro, Shishir Patel, Gabriele Nicolini, Lorenzo Pradelli, Orietta Zaniolo & Alberto Papi. (2013) Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective. Respiratory Medicine 107:10, pages 1531-1537.
Crossref
Crossref
Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström & Brian Godman. (2013) Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future. Journal of Pharmaceutical Health Services Research 4:3, pages 173-181.
Crossref
Crossref
B. Godman, B. Wettermark, J. Miranda, M. Bennie, A. Martin & R. E. Malmström. (2013) Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries. International Journal of Clinical Practice 67:9, pages 853-862.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Peter Skiöld, Björn Wettermark, Corrado Barbui & Lars L. Gustafsson. (2013) Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden. Applied Health Economics and Health Policy 11:4, pages 383-393.
Crossref
Crossref
Sylvain Pichetti, Catherine Sermet, Brian Godman, Stephen M. Campbell & Lars L. Gustafsson. (2013) Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France. Applied Health Economics and Health Policy 11:3, pages 205-218.
Crossref
Crossref
Linda Björkhem-Bergman, Eva Andersén-Karlsson, Richard Laing, Eduardo Diogene, Oyvind Melien, Malena Jirlow, Rickard E. Malmström, Sabine Vogler, Brian Godman & Lars L Gustafsson. (2013) Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. European Journal of Clinical Pharmacology 69:S1, pages 73-78.
Crossref
Crossref
M. Bennie, I. Bishop, B. Godman, C. Barbui, E. Raschi, S. Campbell, J. Miranda & L. L. Gustafsson. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice 67:2, pages 170-180.
Crossref
Crossref
Menno van Woerkom, Hans Piepenbrink, Brian GodmanJoost de Metz, Stephen Campbell, Marion Bennie, Marietta Eimers & Lars L Gustafsson. (2012) Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. Journal of Comparative Effectiveness Research 1:6, pages 527-538.
Crossref
Crossref
Cara Usher, Lesley Tilson, Kathleen Bennett & Michael Barry. (2012) Cost Containment Interventions Introduced on the Community Drugs Schemes in Ireland—Evaluation of Expenditure Trends Using a National Prescription Claims Database. Clinical Therapeutics 34:3, pages 632-639.
Crossref
Crossref
Antoni Sicras Mainar & Ruth Navarro Artieda. (2010) Influencia de la sustitución de medicamentos de marca por genéricos en el cumplimiento terapéutico de la hipertensión arterial y la dislipidemia. Gaceta Sanitaria 24:6, pages 473-482.
Crossref
Crossref
Brian Godman, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Thomas Burkhardt, Kristina Garuolienè, Marija Kalaba, Ott Laius, Roberta Joppi, Catherine Sermet, Ulrich Schwabe, Inês Teixeira, F. Cankat Tulunay, Kamila Wendykowska, Corinne Zara & Lars L Gustafsson. (2010) Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?. Pharmaceuticals 3:8, pages 2470-2494.
Crossref
Crossref